Cook accuses Endologix of stent patent infringement
This article was originally published in Clinica
Executive Summary
Cook is looking to fortify its position as leader in the field of endovascular technology by taking rival Endologix to court over alleged patent infringement. Cook has accused Endologix of infringing one patent that covers its expandable transluminal graft prosthesis for the repair of aneurysms and another that covers the retrieval of percutaneous stents. The litigation seeks to gain damages and to enjoin Endologix from selling all products that infringe these patents.